ArticleExperimental and therapeutic medicine2020
MicroRNA-30d-5p promotes ovarian granulosa cell apoptosis by targeting Smad2.
Article in Experimental and therapeutic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 19 citations in OpenAlex.
- Review
- Comprehensive analysis of proteomics and lactylation proteomics in ovarian granulosa cells of patients with polycystic ovary syndrome.Clinical proteomics · 2026Article
- Clinical significance of microRNA-30d-5p and TGF-β/Smad2 pathway expression levels in polycystic ovary syndrome patients.American journal of translational research · 2026Article
- Beyond Repetition: The Role of Gray Zone Alleles in the Upregulation ofInternational journal of molecular sciences · 2025Article
- Granulosa Cells-Related MicroRNAs in Ovarian Diseases: Mechanism, Facts and Perspectives.Reproductive sciences (Thousand Oaks, Calif.) · 2024Review
- Suppressing the PI3K/AKT Pathway by miR-30d-5p Mimic Sensitizes Ovarian Cancer Cells to Cell Death Induced by High-Dose Estrogen.Biomedicines · 2022Article
- miR-30d-5p: A Non-Coding RNA With Potential Diagnostic, Prognostic and Therapeutic Applications.Frontiers in cell and developmental biology · 2022Review
- rno-miR-128-3p promotes apoptosis in rat granulosa cells (GCs) induced by norepinephrine through Wilms tumor 1 (WT1).In vitro cellular & developmental biology. Animal · 2021Article
- miR-221-3p regulates apoptosis of ovarian granulosa cells via targeting FOXO1 in older women with diminished ovarian reserve (DOR).Molecular reproduction and development · 2021Article
- miR-30d-5p suppresses proliferation and autophagy by targeting ATG5 in renal cell carcinoma.FEBS open bio · 2021Article
- Astrocytic MicroRNA in Ageing, Inflammation, and Neurodegenerative Disease.Frontiers in physiology · 2021Review
- Moxibustion against Cyclophosphamide-Induced Premature Ovarian Failure in Rats through Inhibiting NLRP3-/Caspase-1-/GSDMD-Dependent Pyroptosis.Evidence-based complementary and alternative medicine : eCAM · 2021Article
- CircPSMC3 alleviates the symptoms of PCOS by sponging miR-296-3p and regulating PTEN expression.Journal of cellular and molecular medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycystic ovarian syndrome (PCOS) is one of the leading causes of female infertility. MicroRNA-30d-5p (miR-30d-5p) has been reported to be significantly increased during follicle stimulating hormone (FSH)-mediated progesterone secretion of cultured granulosa cells. However, its role in the proliferation and apoptosis of ovarian granulosa cells is unclear. The present study aimed to investigate the role of miR-30d-5p in the proliferation and apoptosis of ovarian granulosa cells. Bioinformatic analysis and dual-luciferase reporter assay were used to predict and confirm the direct target of miR-30d-5p. The levels of miR-30d-5p were detected via reverse transcription-quantitative PCR (RT-qPCR), cell proliferation was detected via an MTT assay and cell apoptosis was measured via flow cytometry. The levels of phosphorylated (p)-Smad2, Smad2, p-Smad3 and Smad3 were detected by performing a western blot assay or RT-qPCR. In the present results, Smad2 was identified as the direct and functional target of miR-30d-5p. Compared with the control and control plasmid groups, the Smad2 plasmid significantly enhanced Smad2 mRNA levels in rat ovarian granulosa cells, enhanced rat ovarian granulosa cell viability and reduced cell apoptosis. In addition, the results demonstrated that overexpression of miR-30d-5p significantly decreased the level of Smad2, the effect of which was reversed by the Smad2-plasmid. Furthermore, it was demonstrated that the enhanced expression of miR-30d-5p significantly inhibited ovarian granulosa cell proliferation and promoted cell apoptosis. Restoration of Smad2 reversed the effect of miR-30d-5p on ovarian granulosa cell proliferation and apoptosis. Transfection with miR-30d-5p mimics significantly decreased the expression of Smad2 and increased the relative p-Smad2/Smad2 and p-Smad3/Smad3 levels in ovarian granulosa cells, which was reversed by overexpressing Smad2. The present study demonstrated that the overexpression of miR-30d-5p reduced proliferation and induced the apoptosis of granulosa cells by targeting Smad2. The molecular mechanism of ovarian granulosa cell apoptosis may therefore be explained by the newly identified miR-30d-5p/Smad2 axis, which represents a novel potential treatment target for PCOS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.